Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Novel therapeutics in multiple sclerosis management: clinical applications.

Leist T, Hunter SF, Kantor D, Markowitz C.

Am J Med. 2014 Jan;127(1):S2. doi: 10.1016/j.amjmed.2013.06.015.

PMID:
24384114
[PubMed - indexed for MEDLINE]
2.

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.

Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, Oyuela P, Panzara MA, Compston DA; CARE-MS II investigators.

Lancet. 2012 Nov 24;380(9856):1829-39. doi: 10.1016/S0140-6736(12)61768-1. Epub 2012 Nov 1.

PMID:
23122650
[PubMed - indexed for MEDLINE]
3.

Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri).

Pittock SJ, Parisi JE, McKeon A, Roemer SF, Lucchinetti CF, Tan KM, Keegan BM, Hunter SF, Duncan PR, Baehring JM, Matsumoto JY, Lennon VA.

Arch Neurol. 2010 Sep;67(9):1109-15. doi: 10.1001/archneurol.2010.209.

PMID:
20837856
[PubMed - indexed for MEDLINE]
4.

Concurrence of inflammatory bowel disease and multiple sclerosis.

Kimura K, Hunter SF, Thollander MS, Loftus EV Jr, Melton LJ 3rd, O'Brien PC, Rodriguez M, Phillips SF.

Mayo Clin Proc. 2000 Aug;75(8):802-6.

PMID:
10943233
[PubMed - indexed for MEDLINE]
5.

Ubiquitous pathogens: links between infection and autoimmunity in MS?

Hunter SF, Hafler DA.

Neurology. 2000 Jul 25;55(2):164-5. No abstract available.

PMID:
10908883
[PubMed - indexed for MEDLINE]
6.

Orthostatic headaches caused by CSF leak but with normal CSF pressures.

Mokri B, Hunter SF, Atkinson JL, Piepgras DG.

Neurology. 1998 Sep;51(3):786-90.

PMID:
9748027
[PubMed - indexed for MEDLINE]
7.

Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis.

Rivera-QuiƱones C, McGavern D, Schmelzer JD, Hunter SF, Low PA, Rodriguez M.

Nat Med. 1998 Feb;4(2):187-93.

PMID:
9461192
[PubMed - indexed for MEDLINE]
8.
9.

The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system.

Njenga MK, Asakura K, Hunter SF, Wettstein P, Pease LR, Rodriguez M.

J Virol. 1997 Nov;71(11):8592-601.

PMID:
9343217
[PubMed - indexed for MEDLINE]
Free PMC Article
10.
11.

Rational clinical immunotherapy for multiple sclerosis.

Hunter SF, Weinshenker BG, Carter JL, Noseworthy JH.

Mayo Clin Proc. 1997 Aug;72(8):765-80. Review.

PMID:
9276606
[PubMed - indexed for MEDLINE]
12.

Effects of transforming growth factor-beta and platelet-derived growth factor on oligodendrocyte precursors: insights gained from a neuronal cell line.

Asakura K, Hunter SF, Rodriguez M.

J Neurochem. 1997 Jun;68(6):2281-90.

PMID:
9166720
[PubMed - indexed for MEDLINE]
13.

Traumatic occlusion of one limb of an intracranial arterial fenestration: an uncommon cause of stroke.

Schievink WI, Hunter SF, Marsh WR, Aksamit AJ, Jack CR.

Neurology. 1996 Jul;47(1):277-8.

PMID:
8710096
[PubMed - indexed for MEDLINE]
14.

Multiple sclerosis: a unique immunopathological syndrome of the central nervous system.

Hunter SF, Rodriguez M.

Springer Semin Immunopathol. 1995;17(1):89-105. Review. No abstract available.

PMID:
7482229
[PubMed - indexed for MEDLINE]
15.

Isolation of arteriolar microvessels and culture of smooth muscle cells from cerebral cortex of guinea pig.

Seidel MF, Simard JM, Hunter SF, Campbell GA.

Cell Tissue Res. 1991 Sep;265(3):579-87.

PMID:
1786597
[PubMed - indexed for MEDLINE]
16.

O-2A glial progenitors from mature brain respond to CNS neuronal cell line-derived growth factors.

Hunter SF, Bottenstein JE.

J Neurosci Res. 1991 Apr;28(4):574-82.

PMID:
1870158
[PubMed - indexed for MEDLINE]
17.

Growth factor responses of enriched bipotential glial progenitors.

Hunter SF, Bottenstein JE.

Brain Res Dev Brain Res. 1990 Jul 1;54(2):235-48.

PMID:
2397589
[PubMed - indexed for MEDLINE]
18.

Active euthanasia violates fundamental principles.

Hunter SF.

JAMA. 1989 Dec 1;262(21):3074. No abstract available.

PMID:
2810652
[PubMed - indexed for MEDLINE]
19.

Bipotential glial progenitors are targets of neuronal cell line-derived growth factors.

Hunter SF, Bottenstein JE.

Brain Res Dev Brain Res. 1989 Sep 1;49(1):33-49.

PMID:
2791266
[PubMed - indexed for MEDLINE]
20.

CNS neuronal cell line-derived factors regulate gliogenesis in neonatal rat brain cultures.

Bottenstein JE, Hunter SF, Seidel M.

J Neurosci Res. 1988 Jul;20(3):291-303.

PMID:
2852260
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk